tiprankstipranks
CymaBay Therapeutics (DE:C0I)
STUTTGART:C0I

CymaBay Therapeutics (C0I) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
CymaBay Therapeutics’s (C0I) Moving Averages Convergence Divergence (MACD) indicator is 0.66, suggesting CymaBay Therapeutics is a Buy.
CymaBay Therapeutics’s (C0I) 20-Day exponential moving average is 29.42, while CymaBay Therapeutics’s (C0I) share price is €29.8, making it a Buy.
CymaBay Therapeutics’s (C0I) 50-Day exponential moving average is 27.22, while CymaBay Therapeutics’s (C0I) share price is €29.8, making it a Buy.

CymaBay Therapeutics (C0I) Pivot Points

Apr 27, 2024, 12:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
29.80
29.80
29.80
29.80
29.80
29.80
29.80
Fibonacci
29.80
29.80
29.80
29.80
29.80
29.80
29.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

CymaBay Therapeutics (C0I) Moving Averages

Apr 27, 2024, 12:00 PM
Period
Simple
Exponential
MA5
29.80Sell
29.79Buy
MA10
29.76Buy
29.75Buy
MA20
29.66Buy
29.42Buy
MA50
26.99Buy
27.22Buy
MA100
22.86Buy
23.76Buy
MA200
17.43Buy
18.61Buy
CymaBay Therapeutics’s (C0I) 10-Day exponential moving average is 29.75, while CymaBay Therapeutics’s (C0I) share price is €29.8, making it a Buy.
CymaBay Therapeutics’s (C0I) 100-Day exponential moving average is 23.76, while CymaBay Therapeutics’s (C0I) share price is €29.8, making it a Buy.
CymaBay Therapeutics’s (C0I) stock price is €29.8 and CymaBay Therapeutics’s (C0I) 50-day simple moving average is 26.99, creating a Buy signal.
CymaBay Therapeutics’s (C0I) stock price is €29.8 and CymaBay Therapeutics’s (C0I) 100-day simple moving average is 22.86, creating a Buy signal.
CymaBay Therapeutics’s (C0I) stock price is €29.8 and CymaBay Therapeutics’s (C0I) 200-day simple moving average is 17.43, creating a Buy signal.

CymaBay Therapeutics (C0I) Technical Indicators

Apr 27, 2024, 12:00 PM
Name
Value
Implied Action
RSI (14)
65.80
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
83.33
Sell
MACD (12,26)
0.66
Buy
ADX (14)
61.63
Sell
Williams %R
0.00
-
CCI (14)
40.82
Neutral
ATR (14)
0.26
-
ROC
-0.67
Sell
Bull/Bear Power (13)
0.22
Buy
CymaBay Therapeutics’s (C0I) Relative Strength Index (RSI) is 65.80, creating a Neutral signal.
CymaBay Therapeutics’s (C0I) Trend Strength Indicator (ADX) is 61.63, creating a Sell signal.
CymaBay Therapeutics’s (C0I) Commodity Channel Index (CCI) is 40.82, creating a Neutral signal.
CymaBay Therapeutics’s (C0I) Price Rate of Change (ROC) is -0.67, creating a Sell signal.

FAQ

Is C0I a Buy, Hold, or Sell?
Based on C0I’s technical indicators, C0I is a Buy.
    What is C0I’s RSI (14)?
    C0I’s RSI (14) is 65.80, which suggests C0I is a Neutral.
      What is C0I’s MACD?
      C0I’s MACD is 0.66, which suggests C0I is a Buy.
        What is C0I’s 5-day moving average?
        C0I’s 5-day moving average is 29.80, which suggests C0I is a Sell.
          What is C0I’s 20-day moving average?
          C0I 20-day moving average is 29.66, which suggests C0I is a Buy.
            What is C0I’s 50-day moving average?
            C0I’s 50-day moving average is 26.99, which suggests C0I is a Buy.
              What is C0I’s 200-day moving average?
              C0I’s 200-day moving average is 17.43, which suggests C0I is a Buy.
                What is C0I’s Williams % R (14)?
                Currently, no data Available
                What is C0I’s CCI (14)?
                C0I’s CCI (14) is 40.82, which suggests C0I is a Neutral.
                  What is the share price of CymaBay Therapeutics?
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis